Kiwi Wealth Investments Limited Partnership Abb Vie Inc. Transaction History

Kiwi Wealth Investments Limited Partnership

$126 Million
Q4 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $632,337 - $786,902	4,772 Added 9.76%	53,661 $7.23 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $1.21 Million - $1.39 Million	-8,355 Reduced 14.6%	48,889 $7.79 Billion
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $32,087 - $38,481	-232 Reduced 0.4%	57,244 $9.25 Billion
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $767,919 - $976,276	-5,580 Reduced 8.85%	57,476 $8.8 Million
Q1 2022 May 17, 2022	SELL	$131.98 - $163.75 $518,417 - $643,210	-3,928 Reduced 5.86%	63,056 $10.2 Million
Q4 2021 Feb 15, 2022	SELL	$107.43 - $135.93 $781,768 - $989,162	-7,277 Reduced 9.8%	66,984 $9.07 Million
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $5.19 Million - $5.89 Million	48,744 Added 191.03%	74,261 $8.01 Million
Q4 2020 Feb 17, 2021	SELL	$80.49 - $108.67 $316,567 - $427,399	-3,933 Reduced 13.35%	25,517 $2.73 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $9.24 Million - $10.8 Million	-107,521 Reduced 78.5%	29,450 $2.58 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $158,846 - $212,559	2,165 Added 1.61%	136,971 $13.4 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $4.47 Million - $6.77 Million	69,267 Added 105.69%	134,806 $10.3 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $4.73 Million - $5.91 Million	65,539 New	65,539 $5.8 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $4.79 Million - $6.12 Million	-72,844 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$77.14 - $90.79 $748,797 - $881,298	9,707 Added 15.37%	72,844 $5.87 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $215,177 - $265,371	-2,764 Reduced 4.19%	63,137 $5.82 Million
Q3 2018 Nov 15, 2018	BUY	$88.91 - $98.84 $255,260 - $283,769	2,871 Added 4.55%	65,901 $6.23 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $6.56 Million - $7.76 Million	-73,057 Reduced 53.68%	63,030 $5.84 Million
Q1 2018 May 16, 2018	BUY	$92.01 - $123.21 $1.23 Million - $1.65 Million	13,379 Added 10.9%	136,087 $12.9 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $3.43 Million - $3.76 Million	-38,255 Reduced 23.77%	122,708 $11.9 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $11.2 Million - $14.4 Million	160,963	160,963 $14.3 Million

Others Institutions Holding ABBV

# of Institutions

3,785

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

Vanguard Group Inc Valley Forge, PA

171M
Shares

$34.2 Billion
0.57% of portfolio
Black Rock Inc. New York, NY

136M
Shares

$27.4 Billion
0.54% of portfolio
State Street Corp Boston, MA

77.8M
Shares

$15.6 Billion
0.59% of portfolio
Jpmorgan Chase & CO New York, NY

52.1M
Shares

$10.4 Billion
0.84% of portfolio
Capital International Investors Los Angeles, CA

38.6M
Shares

$7.74 Billion
1.4% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $355B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.

Account